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ABSTRACT
Genes involved in detoxification of foreign com-
pounds exhibit complex spatiotemporal expression
patterns in liver. Cytochrome P450 1A1 (CYP1A1),
for example, is restricted to the pericentral region
of liver lobules in response to the interplay between
aryl hydrocarbon receptor (AhR) and Wnt/-catenin
signaling pathways. However, the mechanisms by
which the two pathways orchestrate gene expression
are still poorly understood. With the help of 29 mu-
tant constructs of the human CYP1A1 promoter and
a mathematical model that combines Wnt/-catenin
and AhR signaling with the statistical mechanics of
the promoter, we systematically quantified the regu-
latory influence of different transcription factor bind-
ing sites on gene induction within the promoter. The
model unveils how different binding sites cooperate
and how they establish the promoter logic; it quanti-
tatively predicts two-dimensional stimulus-response
curves. Furthermore, it shows that crosstalk between
Wnt/-catenin and AhR signaling is crucial to un-
derstand the complex zonated expression patterns
found in liver lobules. This study exemplifies how
statistical mechanical modeling together with combi-
natorial reporter assays has the capacity to disentan-
gle the promoter logic that establishes physiological
gene expression patterns.
INTRODUCTION
The liver is the main organ carrying out the metabolism
of many drugs and toxins. One important protein in-
volved in phase I of xenobiotic and drug metabolism is
cytochrome P450 1A1 (CYP1A1). It is regulated by the
aryl hydrocarbon receptor (AhR) which, upon stimulation
with the environmental toxin 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD), translocates into the nucleus where it
binds to its heterodimerization partner Arnt (AhR nu-
clear translocator) (1,2). The so-formed dimer then binds to
dioxin responsive elements (DREs) in the promoter region
of target genes (3–11). The AhR pathway induces strong ex-
pression of CYP1A and other xenobiotic-metabolizing en-
zymes upon stimulation by ligands/toxins such as TCDD.
This leads to altered toxicokinetics of endogenous metabo-
lites and foreign compounds whose metabolism is depen-
dent on AhR-regulated genes. Other effects of AhR activa-
tion include skin toxicity (especially chloracne), tumor pro-
motion and disturbance of developmental processes, at least
in laboratory animals (12).
Expression of many genes in the liver is restricted to cer-
tain regions of a liver lobule, such as the periportal and the
pericentral region (13–21). Many proteins/mRNAs from
various members of the CYP family show an expression
gradient along the portocentral axis, including themembers
of the AhR-regulated CYP1A subfamily (22).
TheWnt/-catenin signaling pathway, which shows high
activity in the perivenous region, has been identified as one
of the major determinants of hepatic zonation (23–25). In
the absence of activating Wnt ligands, the free cytosolic
fraction of the key protein in the pathway, -catenin, is con-
stantly phosphorylated by a large protein complex and thus
marked for degradation by the proteasome. Binding ofWnt
ligands to Frizzled receptors destabilizes the protein com-
plex which in turn allows -catenin to escape degradation,
translocate into the nucleus and initiate target gene tran-
scription via an interaction with T-cell factor (TCF) tran-
scription factors.
In mice it has been observed that a deregulation of the
Wnt/-catenin signaling pathway affects the expression of
Cyp1a genes. While mice with a hepatocyte-specific knock-
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out of Ctnnb1, the gene that encodes for -catenin, lose
the basal expression of Cyp1a (26), mouse hepatomas and
transgenic hepatocytes with activated -catenin show an in-
creased Cyp1a expression even in the absence of TCDD
(27,28). -Catenin and AhR activation synergize in the in-
duction of CYP1A1 expression (22,26,29). Five functional
transcription factor binding sites related to AhR- or -
catenin-dependent signaling have been identified within the
human CYP1A1 promoter: four AhR-binding DREs (3)
and one site that is bound by -catenin/TCF (22). Thus,
both pathways can directly regulate the promoter. Further-
more, a physical interaction between-catenin and theAhR
has been shown (22,30). Still, themolecular details of the in-
terplay between the transcription factors are still unknown.
Previously, there have been various successful attempts to
disentangle the interactions of transcription factorswith the
help of mathematical models, mainly in simpler prokaryotic
systems or invertebrates such as Drosophila melanogaster.
Thermodynamic models that are based on statistical me-
chanics were first introduced in the early ‘80s by Ackers
et al. (31) and Shea and Ackers (32) and further elaborated
on by many others (33–49). For example, with the help of
thermodynamic modeling, Giorgetti et al. (50) showed that
NF-B uses clustered binding sites non-cooperatively. InD.
melanogaster, thermodynamic models were used to explain
the morphogenic gradients (51,52) and the segmentation of
the embryo (53).
How does the CYP1A1 promoter integrate the two sig-
nals originating from theAhRandWnt/-catenin signaling
pathways? How does this integration collude with a possi-
ble cooperative interaction between various TFs binding to
the promoter to regulate a multitude of expression patterns
that give rise to hepatic zonation? To answer these questions
we introduced a library of mutant promoter constructs into
a hepatoma cell and observed their activity in response to
modulation of the two signaling pathways. With the help
of thermodynamic models we untangled the cooperative in-
teraction between the TFs and predicted hepatic zonation
patterns.
MATERIALS AND METHODS
Plasmids
Generation of a pT81luc-based Firefly luciferase reporter
plasmid containing a ∼1200 bp fragment of the human
CYP1A1 promoter has been described previously (54).
This plasmid contains four functional AhR-binding DREs,
termed C, D, E and F, (3) and one -catenin/TCF binding
site, termedT (22).Differentmutant versions of the reporter
were generated by site-directed mutagenesis of individual
transcription factor binding sites using the QuikChange
kit (Stratagene, La Jolla, CA, USA) as recently described
(22). An overview of the mutations introduced is given in
Supplementary Figure S1. Synthetic promoter constructs
were generated containing multiple copies of either C-
DRE (sequence 5′-CGCTTCTCACGCGAGCCGG-3′) or
D-DRE (sequence 5′-GCCGGCGCACGCAAGCTAG-3′)
by cloning synthetic oligonucleotides into the SmaI site of
pT81luc. Versions of the 2× C-DRE plasmid with differ-
ent distances between the two DREs were generated by in-
serting non-AhR-responsive sectors of different size from
the 1.2 kb CYP1A1 promoter fragment between the two C-
DREs of the NaeI-cut pT81-luc/2× C-DRE plasmid, re-
sulting in 2× C-DRE variants with 49, 156 and 292 bp dis-
tance between the two AhR binding sites, respectively. The
integrity of all plasmids was verified by dideoxy sequencing.
In some experiments, a pCMV4-based expression vector for
human AhR was used (27); control cells were transfected
with empty pCMV4. Activity of the -catenin pathway was
monitoredwith the SuperTOPFlash vector, which expresses
Firefly luciferase under the control of eight -catenin/TCF
binding sites (55). Plasmid pRL-CMV encoding Renilla lu-
ciferase under the control of the constitutive cytomegaly
virus promoter (Promega, Mannheim, Germany) was co-
transfected and used for normalization of Firefly luciferase
signals.
Cell culture and transfection
Mouse hepatoma cells from lines 55.1c (22), Hepa1c1c7
and the AhR-deficient sub-clone Hepa12 (56) were cultured
in D-MEM/F-12 medium supplemented with 10 % fetal
bovine serum and antibiotics (all reagents purchased from
Invitrogen, Karlsruhe, Germany) at 37 ◦C and 5 % CO2
in a humidified atmosphere. 55.1c cells carry a heterozy-
gous deletion in exon 3 of Ctnnb1, encoding a constitu-
tively active version of -catenin (Figure 1D). Cells were
seeded on 24-well plates at a density of 40 000 cells/cm2 24
h prior to transfection with Lipofectamine 2000 (Invitro-
gen). Cells were treated with the indicated concentrations
of TCDD (O¨kometric, Bayreuth, Germany) and/or the -
catenin inhibitors iCRT3 (Merck, Darmstadt, Germany),
FH535 (Merck), or PNU74654 (Sigma, Taufkirchen, Ger-
many) for 24 h, starting 24 h after transfection. All com-
pounds were dissolved in dimethylsulfoxide and final con-
centration of the solvent in culture mediumwas 0.2 %. Cells
were lysed with 1× Passive Lysis Buffer (Promega) for 15
min at room temperature. Dual-luciferase assays for Firefly
and Renilla luciferase activities were conducted as recently
described (57). Primary hepatocytes were obtained from
youngmale adultmicewith hepatocyte-specific knockout of
Ctnnb1 (encoding -catenin) by standard collagenase per-
fusion (56) and seeded at a density of 50 000 cells/cm2 on
6-well plates coated with rat tail collagen in D-MEM/F-12
medium supplemented with 10 % fetal bovine serum and
antibiotics. Medium was changed to 1 % serum after 6 h
and cells were treated as described above.
Cell viability and growth analysis
All compounds were tested for the absence of cytotoxicity
by the neutral red uptake and Alamar blue reduction assays
as previously described (58). Cell growth was monitored by
the use of the sulforhodamine B assay according to Skehan
et al. (59). All assays were conducted in octuple determi-
nations on 96-well plates, where cells were seeded at 5 000
cells/cm2 (sulforhodamine B assay) or 9 000 cells/cm2 (cy-
totoxicity assays).
Immunoprecipitation and western blotting
Whole cell lysates were prepared according to Braeuning
et al. (22). Immunoprecipitation was performed at 4◦C
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Figure 1. Cross-talk between AhR and Wnt/-catenin signaling pathways in zonal expression of CYP1A. (A) Hepatic zonation schematic of -catenin
activity and CYP1A expression in response to TCDD treatment. Area of cells displaying high -catenin activity is thought to remain invariant to presence
of TCDDwhile a larger amount of cells express CYP1A after TCDD exposure. (B) Schematic representation of the two signaling pathways that converge on
the CYP1A1 promoter. TCDD can bind to the AhR and Arnt that is then assumed to recruit free -catenin. -catenin is activated (dashed arrow) through
the binding of Wnt to its surface receptors and forms a TF complex with TCF. The CYP1A1 promoter possesses five functional TFBS within 1.2 kbp,
four for TCDD/AhR/Arnt (rectangular binding sites C, D, E, F) and one for -catenin/TCF (elliptical binding site T). The double-headed and numbered
arrows depict the two reactions used in the signaling model. The C- and D-DRE are color coded as in subsequent figures. (C) -Catenin modulates
CYP1A1 expression independently of the -catenin/TCF binding site. Relative luciferase activity of a promoter construct in which the -catenin/TCF
binding site was inactivated by point-mutation over a series of TCDD concentrations treated with DMSO (gray circles) or 10 Mof the -catenin inhibitor
iCRT3 (blue triangles). (D) The interaction between AhR and -catenin is increased upon TCDD treatment. Top: Western analysis of AhR expression in
lysates from 55.1c cells. Co: solvent control; T: 250 nM TCDD for 1 h; T+i: 250 nM TCDD + 10 M iCRT3. Bottom: western analysis of -catenin after
immunoprecipitation with an anti-AhR antibody (AhR AB ‘+’). The two bands show the wild-type (wt) and exon 3-deleted (mut) versions of -catenin,
i.e. the constitutively active -catenin present in the cells.
over night using ProteinG-agarose beads and an antibody
against the AhR (Biomol, Hamburg Germany; 1:200 di-
lution). Whole cell lysates (50 g/lane; protein concen-
tration determined by use of the Bradford assay) or im-
munoprecipitates were separated by SDS-PAGE and trans-
ferred to PVDF membranes. Proteins were visualized by
using antibodies against the AhR (Biomol; 1:1 000), -
catenin (BD biosciences, Heidelberg, Germany; 1:500), or
GAPDH (Merck; 1:1 000) in combination with appropri-
ate alkaline phosphatase-conjugated secondary antibodies
(Millipore, Schwalbach, Germany; 1:10 000) and the sub-
strate CDP-Star (Tropix, Darmstadt, Germany). Chemo-
luminescence was monitored with a CSC camera (Raytest,
Straubenhardt, Germany).
Gene expression analysis
Total RNA was isolated by TRIzol (Invitrogen) and
reverse transcribed using avian myeloblastosis virus reverse
transcriptase (Promega) as described previously (57). Real-
time RT-PCRs were performed on a LightCycler system
(Roche, Mannheim, Germany) using the FastStart DNA
MasterPLUS SYBR Green I kit (Roche) according to the
manufacturer’s instructions and the following primer pairs:
18s rRNA fwd 5′-CGGCTACCACATCCAAGGAA-
3′; 18s rRNA rev 5′-GCTGGAATTACCGCGGCT-3′;
Cyp1a1 fwd 5′-TGTCCTCCGTTACCTGCCTA-3′;
Cyp1a1 rev 5′-GTGTCAAACCCAGCTCCAAA-3′;
Cyp1a2 fwd 5′-GAGCGCTGTATCTACATAAACCA-3′;
Cyp1a2 rev 5′-GGGTGAACATGATAGACACTATTGT-
3′. Data were normalized according to the method
described by Pfaffl (60) with 18s rRNA as a housekeeping
gene.
Animal experiment and immunostaining
Young adult male C3H/HeN mice (n = 5–6 per group)
were treated with the AhR inducer 3-methylcholanthrene
(Sigma; dissolved in corn oil) by a single i.p. injection of
10, 25 or 50 mg/kg body weight 48 h prior to sacrifice.
Mice were killed between 9 and 11 a.m. to avoid circa-
dian variations; livers were excised, transferred to Carnoy’s
fixative and subsequently embedded in paraffin. Tissue
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slices of 5 m thickness were stained for CYP1A as re-
cently described (61) using a rabbit antiserum at 1:500 di-
lution (gift of Dr R. Wolf, University of Dundee, UK) and
a horseradish peroxidase-conjugated secondary antibody
(1:100; Dako, Glostrup, Denmark) with the substrates 3-
amino-9-ethylcarbazole/H2O2. Mice had access to tap wa-
ter and standard chow ad libitum. All animals received hu-
mane care and protocols complied with institutional guide-
lines. Width of CYP1A-positive zones was assessed using
an AxioImager light microscope and AxioVision software
(Zeiss, Oberkochen, Germany).
Data processing
The raw data from the relative luciferase measurements was
preprocessed as described in the following to account for
measurement inaccuracies. For each promoter configura-
tion the means and standard deviations were calculated
from at least three replicates and then normalized to data
without TCDD and -catenin inhibitor. To avoid underes-
timates of standard deviations, we used 10 % of the mean
as the lowest value for the standard deviations, and used a
minimum absolute standard deviation of 0.5 for model cal-
ibration. A linear correction error model for each promoter
construct was used to express standard deviation as a lin-
ear function of the mean. The resulting standard deviations
were then converted into standard deviations of the mean
by dividing by the square root of the number of replicates
for each promoter construct. For details, see supporting text
and refer to the supporting Spreadsheet S13 for the data
sets.
Model implementation
To describe the expression ofCYP1A1 we developed a two-
tier mathematical model. Signaling is represented by mass-
action kinetics, comprising two reversible reactions (TCDD
+ AhR + Arnt ↔ TCDD/AhR/Arnt, TCDD/AhR/Arnt
+ -catenin ↔ TF, cf. Figure 1B), which we assume to be
in thermodynamic equilibrium. Additionally, we assumed
that the total concentrations of AhR plus Arnt, TCDD and
-catenin in the system are constant. Since the total concen-
tration of -catenin was not measured, we multiplied the -
catenin concentration with a parameter describing the ac-
tivity of -catenin that can be modulated by an inhibitor,
leaving the concentration of -catenin free for fitting. The
statistical mechanics model describes the binding of TFs
to binding sites on the promoter. Each TFBS as well as
a separate binding site for the RNA polymerase (RNAP)
is allowed to be either bound or unbound. For every mu-
tant promoter construct this leads to a collection of possi-
ble binding state arrangements. Only those arrangements in
which the RNAP is bound to the DNA are assumed to lead
to transcription. Interaction of two simultaneously bound
TFs is characterized by a binding free energy; all bound
TFs interact with the bound RNAP through another bind-
ing free energy and with the DNA through an association
constant. The formulation of the model follows the formal-
ism developed by Sherman andCohen (45) that leads to one
expression for the binding probability of the RNAP for ev-
ery promoter construct. For comparison with experimen-
tal data each binding probability is normalized to the basal
promoter expression, i.e. when only the RNAP is bound.
The resulting fold-change in binding probability is assumed
to match the observed CYP1A1 expression. For a detailed
deduction of the model, see supporting text.
Model fit
The combination of the equations of the signaling model
and the construct specific binding probabilities served as
objective functions for a weighted non-linear least square fit
(trust-region-reflective algorithm in lsqnonlin, MATLAB
R2013a). We utilized Latin hypercube sampling (62) to gen-
erate a set of 10 000 starting values for optimization. The
ranges of the parameters were limited to be biologically
feasible (e.g. association constants greater zero) and it was
made sure that the resulting optima did not exceed any arti-
ficial boundaries such as an exceeding number of iterations.
The identifiability and confidences of the parameter esti-
mates was then assessed by exploiting the profile likelihood
(63). A detailed description of the algorithm can be found
in the supporting text.
RESULTS AND DISCUSSION
Successful detoxification in the liver requires the induc-
tion of genes involved in the metabolism of exogenous sub-
stances in a spatially confined area. In this work we use the
promoter of the CYP1A1 gene to study exemplarily how
a promoter integrates two stimuli, and how multiple cis-
regulatory elements shape the response and thus the physi-
ological expression pattern of this mammalian promoter.
Interaction between AhR and Wnt/-catenin signaling on
CYP1A expression
Two pathways control the CYP1A1/2 promoters. The AhR
signaling pathwaymediates the response to toxins, while the
Wnt/-catenin signaling pathway, that shows a portocen-
tral gradient, restricts CYP1A expression to the perivenous
region.Without TCDD,CYP1A is only expressed in a small
perivenous area. After AhR activation by TCDD, the re-
gion of expression widens significantly (see schematically in
Figure 1A), although the pattern and strength of -catenin
activity remains invariant (22,29).
Stimulation with TCDD leads to the formation of a
transcription factor (TF) complex containing TCDD, AhR
and Arnt that can bind to the dioxin responsive elements
(DREs) within the CYP1A1 promoter region. Wnt ligands
trigger the accumulation of -catenin, which forms TFs
by binding to TCF. Four known functional transcription
factor binding sites (TFBS) in a ∼1 200 bp upstream re-
gion of the human CYP1A1 gene are recognized by the
TCDD/AhR/Arnt complex (in the following termed C-
DRE to F-DRE) and one by -catenin/TCF (Figure 1B).
To test if the -catenin/TCF binding site is necessary for
the Wnt-mediated expression, we cloned a mutant reporter
construct that contains theCYP1A1 promoter with an inac-
tivated -catenin/TCF TFBS (Supplementary Figure S1).
We transfected this reporter into mouse hepatoma cells
from line 55.1c, then exposed them to increasing concen-
trations of TCDD for 24 h and measured promoter activity
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(Figure 1C). A 4-fold induction was observed.When we ad-
ditionally added a -catenin inhibitor (iCRT3), both basal
reporter activity and induction were drastically reduced, al-
though the inhibitor does not effect the expression of the
Ah receptor (Supplementary Figure S2). This hints to a -
catenin/TCF binding site-independent mechanism of inter-
action between the two pathways.
How do the two pathways now interact to control the
spatiotemporal expression of CYP1A1? First, a direct in-
teraction between the proteins has been reported (22,30).
Second, AhR might be a transcriptional target of Wnt/-
catenin signaling. We performed co-immunoprecipitation
that indeed confirmed a physical interaction between AhR
and -catenin in our cell system (Figure 1D). In particular,
the interaction was strongest when TCDDwas applied, and
was reduced when -catenin activity was inhibited. As over-
expression of AhR did not alter AhR-dependent reporter
activity (Supplementary Figure S3), we concluded that the
amount of AhR was not rate limiting for the regulation of
CYP1A1, and thus modulation of AhR mRNA expression
by -catenin is not relevant for CYP1A1 regulation under
our experimental conditions.
In summary, Wnt/-catenin and AhR signaling are
linked in twoways to regulateCYP1A1: firstly, pathway spe-
cific transcription factors act on the same promoter and,
secondly, some signaling components interact physically.
An interesting aspect is that cross-talk exists without a func-
tional -catenin/TCF binding site. Thus, interactions on
the CYP1A1 promoter are not necessary to establish cross-
talk, and it remains unclear which level of cross-talk would
be the dominating mechanism by which these two pathways
interact in regulating CYP1A1 expression. To dissect this
complex regulation of CYP1A1 in more detail, the quanti-
tative behavior of the response to AhR signaling as well as
the quantitative interaction of both pathways will be stud-
ied in a first step.
Cooperativity between DRE TFBS
AhR signaling converges on four DREs in the promoter of
CYP1A1. Multiple binding sites for TFs can give rise to
cooperative behavior and establish complicated promoter
logic (38,50,64,65). We therefore decided to first investi-
gate the interaction between these sites by constructing pro-
moter mutants in which we systematically point-mutated
the TFBS sequences to disable their function (Supplemen-
tary Figure S1), and then measured their promoter activ-
ity at increasing concentrations of TCDD (Figure 2A). The
first construct in Figure 2A has only one functional, non-
mutated AhR binding site (D-DRE) and shows hardly any
induction by TCDD. In contrast, a construct that has only
the C-DRE binding site available for AhR binding shows
a robust, 2-fold increase in luciferase activity at higher
amounts of TCDD. Finally, for a construct where both the
C-DRE and theD-DRE are present, we observed an almost
4-fold increase in luciferase activity.
Thus, while the D-DRE alone does not change gene in-
duction by TCDD, it cooperates with the C-DRE in induc-
ing expression, demonstrating a more-than-additive coop-
erativity between the interacting TFs that bind to theDREs.
Synthetic promoter constructs confirm cooperativity between
dioxin responsive elements
The cooperative interaction between the TFs that bind to
the C- and D-DRE motivated us to investigate the inter-
action in more detail, in particular how the different bind-
ing site sequences and distances between the binding sites
influence the cooperative behavior. Although both C- and
the D-DRE share an equal core sequence (5’-CACGC-3’),
they differ strongly in the flanking regions (Supplementary
Figure S1), thus they likely differ in binding affinity. To sys-
tematically analyze how these DREs and their interaction
change the promoter response in detail, we constructed syn-
thetic promoter mutants with which we generated quantita-
tive data, and then used a mathematical model to analyze
these. We generated six constructs with one to six copies
of the C-DRE TFBS sequence, three constructs with one
to three copies of the D-DRE TFBS sequence. It should
be noted that the distance of 19 bp between two binding
sites in the C-DRE and the D-DRE constructs is smaller
than the mean TFBS distance of 260 bp in the natural pro-
moter. To analyze the effect of distance, we also cloned four
constructs with two C-DREs placed at increasing distances
from each other (19, 49, 156 and 292 bp, see Figure 2B). The
inserted sequences between the twoC-DREswere notAhR-
responsive. These 13 constructs were then transfected into
55.1c cells, which subsequently were treated with increasing
concentrations of TCDD for 24 h. The measured luciferase
activity data was then preprocessed as described in the Ma-
terials andMethods section and the supporting text. For all
synthetic constructs, in which only one DRE was present,
no significant induction of reporter gene expression for dif-
ferent TCDD concentrations was observed. In contrast, all
remaining constructs showed a dose-dependent induction
(dots in Figure 2D and F). For the C-DRE constructs, we
observed maximal induction for three present DREs. Thus,
adding more binding sites to the constructs does not add
to the inducibility of the promoter but conversely seems
to decrement its induction. If we furthermore compare the
constructs containing different binding sites, i.e. C-DREs
versus D-DREs, we observed that the constructs with C-
DREs showed higher induction than the corresponding D-
DRE constructs. For example, the maximal fold-changes
for the double C-DRE construct was 10, whereas it was at
most two for the double D-DRE construct.
To quantify the effect of the Wnt/-catenin signaling
pathway on gene expression, we established a system to
modulate theWnt/-catenin pathway. Again, we used 55.1c
cells, which express a mutant, constitutively active form of
-catenin (22). We then used the -catenin inhibitor iCRT3
for which we confirmed that it does not act as AhR agonist
(Supplementary Figure S2), shows no cytotoxicity (Sup-
plementary Figure S4), and can efficiently block -catenin
signaling output (Supplementary Figure S5). When we ap-
plied the inhibitor in experiments with the CYP1A1 pro-
moter reporter, we observed that iCRT3 can indeed in-
hibit the induction of the reporter by TCDD (Supplemen-
tary Figures S3 and S6). To calibrate the concentrations
of the iCRT3 inhibitor, we used the 8x -catenin/TCF-
driven SuperTOPFlash reporter and measured luciferase
activity as a proxy for -catenin pathway activity. To ensure
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Figure 2. A mathematical model recapitulates cross-talk and cooperativity between binding sites in the control of a synthetic promoter constructed from
elements of the CYP1A1 promoter. (A) Cooperativity between TFs binding to DREs on the natural promoter. Relative luciferase activity of three natural
promoter constructs over a series of TCDD concentrations was measured. On the three promoter constructs only the following TFBS combinations are
present asWT sequence while the others are inactivated through point-mutation: square: -catenin/TCF andD-DRE; circle: -catenin/TCF and C-DRE;
triangle: -catenin/TCF, C- and D-DRE. (B) Schematic depiction of the synthetic promoter construct library. Six constructs hold one to six copies of the
sequence of the C-DRE (turquois), three constructs hold one to three copies of the sequence of the D-DRE (red), and differently long non-TF responsive
sequences (19, 49, 156, 292 bp) were inserted between two C-DREs for four constructs. (C) Scheme explaining the parameters used in the thermodynamic
model. Ki represent the association constants of the TFs to the C and T TFBS as well as between the RNAP and the DNA. εC and εT are the binding
energies between the TFs and the RNAP while εTC is the interaction term between the TFs. (D) TCDD concentration series of the synthetic promoter
constructs can be explained with a thermodynamic model. TCDD concentration series of nine synthetic constructs as well as one -catenin titration series
where the relative luciferase activity was measured (gray dots and blue triangles). The upper seven graphs represent the C-DRE constructs while the lower
three graphs represent D-DRE constructs. The graph in the top right corner shows a -catenin titration series measured at 250 nM TCDD concentration.
Error bars represent one standard deviation of 6–10 biological replicates. The black curves show the fits of the thermodynamic model. (E) Cooperative
binding dominates the synthetic promoter constructs. Binding energies resulting from fits are displayed on the promoter construct holding six copies of the
C-DRE. Arrows depict significant binding events. Their colors represent binding strength where lower values represent stronger association. All binding
events were present in the model. Those equal or close to 0 are not depicted as arrows. (F) Stimulus-response curves for constructs with different distances
betweenDREs confirm reduced cooperativity for longer distances. Relative luciferase activity was measured over increasing TCDD concentrations for four
promoter constructs with different distances (19, 49, 156, 292 bp) between their C-DREs. (G) Model simulations showing why three C-DRE binding sites
showmaximal induction. Top: The average number of occupied binding sites is plotted over the number of present binding sites in the synthetic constructs.
Bottom: The probability that the first DRE, i.e. the one closest to the RNAP is occupied by TFs is shown. Note that these values were calculated for 250
nM of TCDD. (H) Thermodynamic model correctly predicts and experimental data and confirms an AND gate relationship between the Wnt/-catenin
and the AhR signaling pathway on the 3× C-DRE construct. Left: prediction of the promoter activity of the synthetic construct holding three C-DREs
by the thermodynamic model through variation of the -catenin activity parameter. Right: corresponding measurements of the relative luciferase activity
of the 3× C-DRE construct where the inhibitor iCRT3 modulated the -catenin activity. The cells were stimulated with increasing TCDD concentrations.
the specificity of the observations, the experiments were re-
peated using a second, structurally unrelated -catenin in-
hibitor, FH535 (Supplementary Figures S2–S6). The results
obtained with FH535 closely resemble the findings with
iCRT3. We used the iCRT3 inhibitor to generate quantita-
tive data on the construct with three C-DREs, which shows
reduction in relative luciferase activity when the -catenin
pathway activity is reduced (Figure 2D, top right).
A thermodynamic model can explain binding site coopera-
tivity. To understand in more detail, how the different
binding sites interact, we decided to describe this behav-
ior with the help of a mathematical model. The model has
two tiers. The first tier of the model describes the signaling
events leading to the formation of the TFs (cf. Figure 1B).
This includes the reversible binding of TCDD to AhR and
its nuclear translocator Arnt. Furthermore, the association
between -catenin and the TCDD/AhR/Arnt complex is
modeled. The second tier of the model is the binding of
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the TFs to the binding sites in the promoter, which we
decided to model by a thermodynamic approach that de-
scribes binding probabilities as function of binding energies
(cf. Figure 2C for parameters types used in the model). Our
thermodynamic model assumes that the described system
operates in thermodynamic equilibrium, similarly to previ-
ous work (31,33,35,40,45,46,49,53,66). Since we determine
expression on long time-scales, it is likely that the system
is at least in steady state, and thus could likely be describe
with such an approach. This model includes a binding site
for the RNA polymerase (RNAP), and we use the probabil-
ity of bound polymerase as a proxy for gene expression. A
detailed description and deduction of the model expression
can be found in the Materials and Methods and the sup-
porting text. The model assumes that AhR concentration is
not the limiting step in the pathway, as we found that AhR
Co-transfection with different reporter constructs (WT, 3×
C-DRE) does not change the measured luciferase activity,
even when the cells are stimulated with TCDD (Supplemen-
tary Figure S3).
To model the behavior of the synthetic promoter con-
structs, we fitted the mathematical models for one to six C-
DREs and one to three D-DREs at the same time to the
data consisting of the TCCD titration series (gray circles in
Figure 2D) and to one -catenin titration series (blue tri-
angles in Figure 2D). Between all these models, those pa-
rameters that describe the same biological process were kept
equal, limiting the total number of free parameters. For ex-
ample, the binding energy between the TF that binds to the
first DRE and the polymerase was the same in all models
because the same TF binds to all the TFBS. Additionally,
interaction over the same distances was assumed to be car-
ried out by the same binding energy, i.e. there was one pa-
rameter for neighboring TFs, one for binding over one in-
termediate, etc. Furthermore, the association constants of
all constructs using C-DREs were the same, and those con-
structs using D-DREs had a different parameter. Overall,
all models had 17 parameters that were then simultaneously
fitted to the corresponding data sets. Using this strategy, we
could fit the data set in most quantitative detail (compare
solid lines which represent the best model fit with dots that
represent the experimental data in Figure 2D). Even though
the data of the C-DRE and the D-DRE constructs differed
significantly, they could be explained by only one differing
parameter that models the binding affinity of the transcrip-
tion factor to the DRE sequences. In particular, binding
affinity of the TFs to the C-DREs is 4× stronger than that
to the D-DREs (cf. Supplementary Table S1). The model
fit also reproduces the resulting strong sigmoidal response.
All constructs show an almost switch-like behavior if the
TCDD concentration is increased.
Binding site cooperativity limited to neighboring TFBS.
The parameters produced by the model fitting routine now
helped us to understand how the TFs interact to modu-
late various induction behaviors of the synthetic constructs
(Figure 2E). To obtain confidence intervals for the parame-
ters, we used the profile likelihood approach (63). Applying
a point-wise confidence threshold, i.e. confidence intervals
that hold individually for each parameter, we find that all
parameters had a clear minimum and thus are identifiable.
Ten of the parameters were significantly larger than zero,
most with relatively small confidence intervals, while the re-
maining seven parameters (ε2, ε4, εd3, ε5, εd4, ε6, εd5) were
indistinguishable from zero, i.e. the model can fit the data
without these interactions (Supplementary Figure S7 and
Table S1). Strongest binding between TFs occurs over short
distances whereas binding to the polymerase is only signifi-
cant for the TFs binding to the first TFBS. Longer distance
binding between TFBS and RNAP is either zero or close to
zero, as is longer distance cooperative binding between TFs
(Supplementary Figure S8). These modeling results could
also be confirmed by the promoter constructs with varying
distances between the TFBSs (Figure 2F). Here, the maxi-
mal fold-change of ∼12-fold can be observed for the small-
est distance of 19 bp between the TFBS. With increasing
distance the maximal induction decreases to ∼10-fold for a
distance of 49 bp and to ∼2-fold for the distances 156 and
292 bp. It is apparent that the inducibility decreases with
increasing distance between the TFBS, suggesting that, as
predicted by the model parameters, long distance coopera-
tion is limited. The importance of distance between TFBS
was also investigated using similar approaches for the Hep-
cidin promoter, where cooperativity between nearby bind-
ing sites for BRE1 and STATBS was essential to reproduce
the stimulus-response curves with a mathematical model
(64).
Sequestration is responsible for reduced transcriptional in-
duction. A counterintuitive aspect of the data is that
adding more DREs to the promoter does not necessar-
ily lead to increased transcriptional output. Adding more
than three DREs rather decreases activity (Figure 2D).
Interestingly, the mathematical model can accurately de-
scribe that behavior. This can be explained as follows: first,
only the most proximal DRE significantly interacts with
the RNAP, therefore transcription is only initiated if the
TCDD/AhR/Arnt/-catenin TF complex is bound to the
first DRE. Second, the DREs only interact over short dis-
tances, i.e. with the neighboring DRE and the DRE next to
its neighbor. In the case when there are two DREs present,
the second DRE can interact with the first and thus in-
crease transcriptional output. Similarly, if three DREs are
present both the second and the third DRE can interact
with the first DRE and further increase the transcriptional
output. However, if the construct holds four DREs, the
forth DRE cannot directly interact with the first DRE be-
cause the model parameters were zero for long range inter-
actions. Since only pairwise interactions can occur, there
are states where the second, third and forth DRE inter-
act with each other but none of them with the first DRE.
This reduces transcriptional output and can thus be viewed
such that the fourth, fifth and sixth DRE sequester inter-
action partners for the first DRE. This hypothesis is also
supported by the calculation of the average number of oc-
cupied binding sites as well as the probability that the first
TFBS is bound by a TF (Figure 2G). While no TFs are
bound on average if only one C-DRE is present (explain-
ing the lacking induction of the 1× C-DRE construct in
Figure 2D), one TFBS is occupied in the 2× C-DRE con-
struct. The maximum number of occupied TFBS is reached
in the 3× C-DRE. Adding more DREs thus does not in-
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crease the mean number of bound binding sites (Figure 2G,
top). Likewise, looking at the probability that the first and
thus the strongest cooperator with the RNAP is bound to
its binding site we see a peak for the 3× C-DRE construct.
This means that the same number of TFs may distribute
over four and more TFBS resulting in states where the first
TFBS is unoccupied (Figure 2G, bottom) and hence induc-
tion is reduced.
In summary, while the number of occupied binding sites
remains constant for three andmoreDREs, the present TFs
have more possibilities to bind to the promoter leading to
a decreased probability that the first DRE is occupied. And
since the TF bound to the first DRE interacts most strongly
with the RNAP this leads to decreased induction of the 4×
to 6× C-DRE constructs.
The thermodynamic model can predict signal integration by
the synthetic promoter. Aswe have now established amod-
eling framework that can describe the response of the syn-
thetic constructs to TCDD stimulation well, we next de-
cided to include the impact of the Wnt/-catenin signal-
ing pathway on the promoter. As the model was trained in
cells that have a constitutively active Wnt/-catenin path-
way, we simulated inhibition of -catenin signaling in our
model by reducing the parameter representing -catenin ac-
tivity. When plotting the predicted response of the model
describing the 3×C-DRE promoter construct as a function
of TCDD and -catenin activity, it becomes apparent that
the promoter requires both Wnt/-catenin and AhR sig-
naling pathways to be active and responds in a sharp ultra-
sensitive way, resembling the behavior of a logic AND gate
(Figure 2H, left).
We then generated a data set by systematically varying the
-catenin activity and the TCDD concentration, and after-
wardsmeasured reporter activity for the synthetic construct
with triple C-DREs (Figure 2H right). As predicted by the
model, a decrease in -catenin activity through inhibition
with iCRT3 results in lower luciferase activity. Similarly, a
smaller TCDD stimulus leads to a decrease in CYP1A1 ex-
pression. Even though a full inhibition of -catenin activ-
ity and thus a complete shut-down of CYP1A1 induction
is experimentally not accessible, this data is in quantitative
agreement with themodel predictions, confirming theAND
gate behavior between the Wnt/-catenin and AhR path-
way as predicted by the model in the experimentally acces-
sible range (Figure 2H, left).
We also investigated the behavior of other constructs that
included the D-DREs, where we could also see an agree-
ment with the model predictions and the AND-gate behav-
ior, however less pronounced (Supplementary Figure S9).
A model for signal integration of the human CYP1A1 pro-
moter
After we had established that our mathematical model can
indeed describe the behavior of the well-controllable syn-
thetic promoter constructs, we next decided to use this ap-
proach to analyze the human CYP1A1 promoter. Similarly
as with the synthetic constructs, we generated a promoter
reporter library with 17 different combinations of pointmu-
tations that inactivate specific TFBS (Figure 3A and Sup-
plementary Figure S1). Each of these reporters was then
transfected into mouse hepatoma cells of line 55.1c and
treated with increasing concentrations of TCDD for 24 h.
The measured luciferase activity data was preprocessed as
described in the Materials and Methods section and the
supporting text. From the resulting dataset (gray dots in
Figure 3B), it can be seen that the behavior of the nat-
ural promoter is less obvious than that of the synthetic
promoter constructs. For example, the promoter that con-
tains all binding sites except the F-DRE (EDTC construct)
shows the strongest induction upon TCDD treatment, even
stronger than the WT construct that harbors all binding
sites. Furthermore, it was observed that constructs DTC,
FTC, EDT, FET, FDTC, FEDC and FEDT displayed al-
most the same inducibility although there are different types
and numbers of TFBS present. Finally, it was surprising
that the constructs TC and ET presented with a 3-fold in-
ducibility while the construct DT is hardly inducible at all.
To disentangle the effects of the different binding sites
and analyze if the behavior of the promoter can be un-
derstood by the interactions between the binding sites, we
again set up a model. The association constants for the
C-DRE and D-DRE could be taken from the model fit
of the synthetic promoter constructs. Within the synthetic
constructs we have seen that cooperative binding is only
present between direct or next neighbors, which led us to
eliminate long-distance interactions from the model (be-
tween C-DRE and E-DRE, C-DRE and F-DRE, and -
catenin/TCF and F-DRE). Furthermore, if a binding site
is inactivated through a mutation in the construct we re-
moved the mutant TFBS from the model by setting the cor-
responding association constant between TF and TFBS to
zero.
When fitting the remaining 19 parameters to the entire
data including a -catenin titration series (blue triangles in
Figure 3B) we see that the model can recapitulate the data
well, except for the very strong induction of the constructs
EDTC andFETC (Figure 3B). Thatmay be a result ofmore
complex cooperativity between three factors, which we did
not include in the model.
An interesting aspect of the experimental data and the
model is that, compared to the syntheticmodel (Figure 2D),
the induction of the natural promoter (Figure 3B) showed a
less pronounced sigmoidality, i.e. not such a strong switch-
like behavior.
Cooperativity in the wild type promoter. To understand in
more detail how the difference in the sigmoidality of the
stimulus-response curves can arise, we investigated the pa-
rameter values. We used the profile likelihood method to
determine confidence intervals and to analyze which pa-
rameters can be robustly estimated from the experimental
data (63). We found that 18 of the 19 parameters showed a
clear minimum and thus were identifiable by the data, when
we apply point-wise confidence thresholds. Two of the pa-
rameters (qP and εD) were indistinguishable from zero, i.e.
irrelevant for the model to describe the data. Only the co-
operative binding energy between the D- and the E-DRE
was practically non-identifiably (according to the terminol-
ogy in (63)) and thus could not be reliably determined from
the data (Supplementary Figures S10 and S11). When we
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Figure 3. Promoter logic of the human CYP1A1 promoter dissected by a mathematical model. (A) Schematic representation of the reporter library for the
natural CYP1A1 reporter. Rectangular binding sites are DREs while elliptical binding sites are targets of -catenin/TCF. Gray symbols depict TFBS that
were inactivated by point-mutation while theWT binding sequence is represented by black symbols. (B) The response of the natural promoter constructs to
TCDDconcentration series can be explainedwith a thermodynamicmodel. Relative luciferase activity wasmeasured over increasing TCDDconcentrations
and an additional -catenin titration for 18 natural promoter constructs (gray dots and blue triangles). The -catenin titration was measured at 250 nM
TCDD. Error bars represent one standard deviation of 4–10 biological replicates. The black solid curves show the fits of the mathematical model. (C)
Binding between the RNAP and the TFs dominates the natural promoter constructs. Binding energies resulting from fits displayed on the natural promoter.
Arrows depict existing binding events. Their colors represent binding strength where lower values represent stronger association. Only short range binding
events were considered in the model, those equal or close to zero are not depicted as arrows. (D) Predicted response to Wnt/-catenin and AhR signaling
pathway for three different natural promoter constructs. Left: prediction of the promoter activity of three natural constructs (C-DRE and -catenin/TCF
TFBS present; -catenin/TCF TFBS inactivated through point-mutation; WT construct) by the mathematical model through variation of the -catenin
activity parameter. Right: Corresponding measurements of the relative luciferase activity of three constructs where the -catenin activity was modulated
by the iCRT3 inhibitor. The cells were simultaneously stimulated with increasing TCDD concentrations. (E) Hill Coefficients confirm more switch-like
behavior of synthetic promoter constructs. From the double-stimulated datasets of the synthetic 3× C DRE and the natural WT promoter construct the
subsets for 100 % -catenin activity was fitted to Hill functions. Relative luciferase activity for both constructs is represented by turquoise (synthetic 3×
C DRE construct) and black (natural WT construct) dots. The dashed lines depict the corresponding Hill functions. The resulting Hill coefficients for the
two constructs are shown.
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furthermore compared the interaction energy between the
TFs and the RNAP with those from the synthetic promot-
ers, we found that they were generally higher in the natu-
ral promoter constructs, and that they were relatively in-
dependent of the distance to the RNAP binding site (Fig-
ure 3C, Supplementary Figure S10 and Supplementary Ta-
ble S2). While the binding energy between the D-DRE and
the RNAP is zero, its cooperative interaction with the -
catenin/TCF TF is the strongest. On the other hand, the
strong binding energies of the C-DRE and the E-DRE with
the RNAP resulted also in strong cooperative interactions
to the remaining TFBS. But most interesting is the strong
influence of the -catenin/TCF TFBS. It not only has the
strongest connection with the RNAP but also communi-
cates most strongly with its direct or next neighbors.
The model is able to predict signal integration by the pro-
moter. After having established a model that is able to
quantitatively describe the response to TCCD stimulation,
we aimed to predict how TCCD and -catenin are inte-
grated on the CYP1A1 promoter (Figure 3D). We first sim-
ulated a construct where all TFBS were mutated except
the most proximal C-DRE and the -catenin/TCF bind-
ing site. The model predicted a weak induction that requires
both -catenin and TCDD signaling (Figure 3D top left),
which is similar to what we observed when we measured
the reporter activity for this construct for varying concen-
trations of TCDD and -catenin (Figure 3D top right).
Next, we investigated the behavior of the promoter where
only the -catenin/TCF site is mutated, allowing us to see
if the model correctly predicts the cross-talk of AhR and
Wnt/-catenin signaling that occurs upstream of the pro-
moter. The model predicts a 3- to 4-fold induction if both
-catenin and TCDD are at high doses, and shows rather
shallow stimulus-response curves (Figure 3D, middle left).
Similarly, the corresponding experimental data set shows a
3-fold induction by TCDD that is modulated by -catenin,
confirming that strong regulatory cross-talk occurs inde-
pendently of the -catenin/TCF binding site (Figure 3D,
middle right). Finally, when simulating the full model rep-
resenting the WT promoter, we observe a stronger, ∼5-fold
induction that shows a gradual increase with both TCDD
and -catenin, which closely resembles that of the experi-
ment (Figure 3D bottom left and bottom right). When we
compared thosemeasurements with the TCDD titration ex-
periments, it was reassuring to see that these independent
experiments were in good agreement (Supplementary Fig-
ure S12).
When comparing experimental data and mathematical
model from the natural promoter with the synthetic pro-
moter, we noticed that the stimulus-response pattern was
less switch-like in the natural promoters. To quantify the
differences in steepness of the dose-response curves between
the synthetic and the natural promoter constructs, we cal-
culated the Hill coefficients by fitting Hill functions to the
dose–response curves for TCDD of the synthetic 3× C
DRE as well as the natural WT promoter construct (Fig-
ure 3E). The resulting Hill coefficients are 3.21 and 2.17 for
the synthetic and the natural construct confirming a more
switch-like behavior of the synthetic constructs.
In summary, CYP1A1 expression requires the simultane-
ous presence of two signals, as a single stimulant –– TCDD
or -catenin –– is not sufficient to trigger full CYP1A1 ex-
pression. Thereby expression is restricted to the pericentral
zone of a liver lobule where -catenin levels are high. This
behavior closely resembles a logical AND gate, which has
been widely discussed in recent literature (37,39,40,67,68).
It is interesting to see that the apparent AND-gate logic
of the CYP1A1 promoter is established not only by inter-
actions between the cis-regulatory binding sites, but in ad-
dition also by the interaction between Wnt/-catenin and
AhR signaling pathways.
In another study, modeling the thermodynamics of cis-
regulatory binding sides of the hepcidin promoter, it was
shown that the response to two different pathways (SMAD
and STAT) did not follow an AND gate, although some
mutants, which are associated with hereditary hemochro-
matosis, did. This reemphasizes the evolutionary plasticity
of promoter logic (64).
Thermodynamic model predicts physiological zonation pat-
tern. We reasoned that less switch-like behavior might be
important for zonal gene expression: if no exogenous AhR
agonists are present, the area ofCYP1A1 expression around
the central vein is small and restricted to very high-catenin
activity, whereas it extends larger into periportal regions
when AhR receptors are stimulated (Figure 4). Similarly, in
ourmodel the expression of the reporter remains low in cells
that show 28 % of -catenin activity until TCDD concen-
trations rise above 10–50 nM and increases at higher doses.
In contrast, cells with 100 % -catenin activity show strong
and saturating expression already at 5 nM TCDD.
To compare predicted spatial expression patterns with
data, we mapped the model predictions for different TCDD
concentrations on hexagonal grids that are similar to liver
lobules, and assumed a linear gradient for -catenin from
the center to the periphery of each hexagon (Figure 4, top).
This type of gradient was deduced from immunohistochem-
ical images showing zonation of active -catenin in mouse
liver (23). For the TCDD concentration, we assumed that
the applied TCDD concentration will distribute evenly over
the whole lobule. We then performed immunostainings of
CYP1A in mouse livers treated with different concentra-
tions of the AhR inducer 3-methylcholanthrene (3-MC)
(Figure 4 bottom). When comparing these patterns, we saw
that without stimulation, the experimental data showed a
basal perivenous expression of CYP1A that was not pre-
dicted by our model. Most probably, the reason for this is
that the AhR retains basal activity in the liver due to the
presence of low levels of endogenous AhR agonists (e.g.
comparable to the 5 nM TCDD in our stimulations). For
10 mg/kg body weight 3-MC a broadening of the CYP1A-
expressing region around the central veins could be ob-
served while higher concentrations of 3-MC only lead to
an increased expression intensity (represented by darker
browns). This effect could be replicated well with the ther-
modynamic model.
While the thermodynamic model can accurately de-
scribe the promoter logic of the promoters in the luciferase
assays, it should be noted that the fold-change of the
CYP1A1 gene is higher in the promoter of human cell lines
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Figure 4. Model predicts spatial expression ofCYP1A1 as a result of its promoter logic. Top: Predictions of the thermodynamicmodel for theWT construct
for selected TCDD concentrations. Each hexagon represents an idealized hepatic lobule that is exposed to a -catenin activity gradient from central vein
(high) to portal vein (low). Bottom: Representative immunostainings of mouse liver for CYP1A for different concentrations of 3-MC.
(HepG2, CaCo-2, HT116) when compared to luciferase as-
says (29,54). Thus, the model captures the essence of the
promoter logic, but additional factors such as other bind-
ing sites or chromatin composition may influence the fold-
change. It should also be noted that the kinetic details of the
interactions in the promoter will determine how large the
zone of expressionwill be and if the zonewidens if toxins are
present. While the described interaction of Wnt/-catenin
and AhR is sufficient to describe zonation of the CYP1A
expression, it is likely that the zonation of other genes is
controlled by different and/or additional mechanisms. The
expression of glutamine synthetase (GS), for example, is re-
stricted to a small pericentral zone which can be explained
with an additional regulatory mechanism that silences an
5′-enhancer within the GS gene (69).
Taken together, we reasoned that interactions between
Wnt/-catenin and AhR at the signaling level, together
with the complex cooperative interactions between the
DREs in the human CYP1A1 promoter enable the spa-
tiotemporal expression pattern observed in vivo.
CONCLUSION
There is currently a huge discrepancy in the level of detail
for the quantitative description of signaling systems and
gene regulation for mammalian cells. There is for exam-
ple a large body of literature on kinetic models of kinase
signaling (70). In contrast, most models of gene regulation
in mammalian cells address the behavior and dynamics of
larger networks neglecting the regulatory complexity of a
promoter, leaving the question open of how the regulatory
logic of a promoter is established. There have been a few
notable exemptions recently that either use more complex
input-output functions (71), or make use of a thermody-
namic description of the promoter (50,64). An interesting
aspect of our model is that it can fully describe the be-
havior of the promoter by a thermodynamic equilibrium,
i.e. purely by binding between the proteins of the signaling
pathways with each other and the promoter.
During recent years, statistical models have been devel-
oped that can be trained on genome-wide data, such as tran-
scription factor binding data, open chromatin, and histone
marks to predict gene expression (72,73). These models are
phenomenological, and it would be interesting to combine
these with a thermodynamic description, as it has been done
previously for gene expression in D. melanogaster develop-
ment (53).
Taken together, our work demonstrates that statistical
mechanics modeling together with combinatorial reporter
libraries can be successfully applied to dissect the molecular
details that establish promoter logic. This provides insight
into how physiological relevant expression patterns are es-
tablished.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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